About
Vaccines, Biologics
Areas of Focus
Categories
Biologics & BiopharmaceuticalVaccine
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
1,270
By Phase
PHASE2/PHASE3: 1PHASE1/PHASE2: 2PHASE1: 1
By Status
COMPLETED: 3NOT_YET_RECRUITING: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT07204457Lead Sponsor
Immunogenicity and Safety of Meningococcal Conjugate Vaccine (EG-MCV4) in Healthy Adults Aged 19 to 55 Years Old
PHASE2/PHASE3Not yet recruiting
1,123 participants
Started: Oct 31, 2025 · Completed: Jun 30, 2027
NCT06099613Lead Sponsor
Study to Safety, Tolerability and Immunogenicity of EG-COVII in Healthy Adult
PHASE1/PHASE2Completed
40 participants
Started: Nov 30, 2023 · Completed: Feb 28, 2025
NCT05188469Lead Sponsor
Study to Assess the Safety, Tolerability and Explore the Immunogenicity of EG-COVID and EG-COVARo in Healthy Adult Volunteers
PHASE1/PHASE2Completed
67 participants
Started: Mar 22, 2022 · Completed: Feb 28, 2025
NCT04210752Lead Sponsor
Study to Assess the Safety, Tolerability and Explore the Immunogenicity of EG-HZ in Healthy Adult Volunteers
PHASE1Completed
40 participants
Started: Feb 24, 2020 · Completed: Dec 3, 2020
Locations (1)
Headquarters
Uiwang, Korea
Map
Loading map...